September 10, 2025
OXFORD, UK and CLEVELAND, Ohio, US, 10 September 2025 – The Oxford-Harrington Rare Disease Centre (‘OHC’), a partnership between the University of Oxford, UK and Harrington Discovery Institute at University Hospitals, Cleveland, Ohio, dedicated to creating new medicines for rare diseases, announces that Lord...
Continue ReadingAugust 22, 2023
A Conversation with Jonathan S. Stamler, MD, President of Harrington Discovery Institute Continue Reading